Compliance News | January 6, 2023
On December 23, 2022, the Departments of Labor, Health and Human Services and Treasury (the Departments) published guidance concerning compliance with the requirement for sponsors of group health plans to file reports about prescription drug costs and other plan information with the federal government. This process, known as RxDC reporting, requires group health plans to coordinate production of eight spreadsheets that must be uploaded into the Health Insurance Oversight System (HIOS). The reporting deadline was December 27, 2022.
The guidance states that the Departments will not take enforcement action with respect to group health plans that use a good-faith, reasonable interpretation of the regulations and RxDC Reporting Instructions in making its submission of the 2020 and 2021 data.
In addition, the Departments announced a submission grace period through January 31, 2023. Consequently, group health plans that make a good-faith submission of the 2020 and 2021 data by January 31, 2023, will not be considered out of compliance with RxDC reporting requirements.
The guidance mentioned above was issued as FAQ 56.
The Departments also provided the following clarification and flexibility with respect to submitting the required 2020 and 2021 data:
The Departments have not announced a good-faith rule for 2022 data, which must be filed by June 1, 2023. However, they stated that they will continue to review whether additional guidance is necessary.
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
Don't miss out. Join 16,000 others who already get the latest insights from Segal.